CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $35.98 ($359,800)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $38.63 ($386,270)
- 4 Open-market sale President and CEO sold 8,333 shares at an average $37.55 ($312,873)
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $35.00 ($350,000)
- 4 Open-market buy Director bought 10,000 shares at $38.03 ($380,252)
- 4 Open-market buy Director bought 6,700 shares at $37.28 ($249,780)
- 4 Open-market sale President and CEO sold 8,333 shares at $31.95 ($266,239)
- 4 Open-market sale President and CEO sold 8,333 shares at an average $32.16 ($267,969)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 40,000 shares at an average $38.06 ($1,522,440)
- 4 Open-market sale President and CEO sold 9,134 shares at $45.00 ($411,030)
- 4 Open-market sale President and CEO sold 8,333 shares at an average $35.72 ($297,693)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 18,000 shares at an average $34.21 ($615,840)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 18 · 351 filings